Advertisement
Loading...

Boiron SA

BOIRF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$31.90
$1.90(6.33%)
U.S. Market is Open • 14:53
Advertisement

Boiron SA (BOIRF) Stock Overview

Explore Boiron SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap553.9M
P/E Ratio24.54
EPS (TTM)$1.32
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$29.66
3 Months$31.14
1 Year Target$17.53

BOIRF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Boiron SA (BOIRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $17.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.54 and a market capitalization of 553.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
6.33%
3-Month Change
6.33%
6-Month Change
6.33%
Year-to-Date (YTD) Change
6.33%
1-Year Change
11.93%
3-Year Change
-26.45%
5-Year Change
-31.84%
All-Time (Max) Change
1.66%

Contact Information

https://www.boiron.fr
33 4 78 45 61 00
2, avenue de l’Ouest Lyonnais, Messimy, NaN, 69510

Company Facts

24,690 Employees
IPO DateMay 2, 1996
CountryFR

Frequently Asked Questions